Cargando…
miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness
Rationale: Chemoresistance and subsequent recurrence of human urothelial bladder cancer (UBC) is partially driven by a subpopulation of tumor initiating cells, namely cancer stem cells (CSCs). However, the underlying molecular mechanism in chemotherapy-induced CSCs enrichment and following chemoresi...
Autores principales: | Zhang, Qing, Zhuang, Junlong, Deng, Yongming, Yang, Lin, Cao, Wenmin, Chen, Wei, Lin, Tingsheng, Lv, Xiaoyu, Yu, Hang, Xue, Yanshi, Guo, Hongqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706099/ https://www.ncbi.nlm.nih.gov/pubmed/29187903 http://dx.doi.org/10.7150/thno.21713 |
Ejemplares similares
-
GOLPH3 is a potential therapeutic target and a prognostic indicatior of poor survival in bladder cancer treated by cystectomy
por: Zhang, Qing, et al.
Publicado: (2015) -
O(2)-generating MnO(2) nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia
por: Lin, Tingsheng, et al.
Publicado: (2018) -
Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment
por: Lin, Tingsheng, et al.
Publicado: (2020) -
Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis
por: Zhang, Wenlong, et al.
Publicado: (2022) -
GOLPH3L antagonizes GOLPH3 to determine Golgi morphology
por: Ng, Michelle M., et al.
Publicado: (2013)